electroCore, Inc. (NASDAQ:ECOR - Free Report) - Research analysts at HC Wainwright increased their Q3 2026 earnings estimates for shares of electroCore in a report released on Friday, August 7th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of ($0.25) for the quarter, up from their previous forecast of ($0.26). The consensus estimate for electroCore's current full-year earnings is ($1.48) per share. HC Wainwright also issued estimates for electroCore's Q4 2026 earnings at ($0.19) EPS, FY2026 earnings at ($1.34) EPS, Q1 2027 earnings at ($0.22) EPS, Q2 2027 earnings at ($0.30) EPS, Q3 2027 earnings at ($0.17) EPS, Q4 2027 earnings at ($0.11) EPS, FY2027 earnings at ($0.81) EPS, FY2028 earnings at ($0.39) EPS, FY2029 earnings at $0.15 EPS and FY2030 earnings at $0.65 EPS.
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of electroCore in a research note on Wednesday, June 24th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $18.00.
Check Out Our Latest Stock Analysis on ECOR
electroCore Stock Performance
Shares of ECOR opened at $8.96 on Tuesday. The business's fifty day moving average is $7.67 and its 200-day moving average is $7.01. The firm has a market cap of $80.82 million, a price-to-earnings ratio of -5.40 and a beta of 0.93. electroCore has a 52-week low of $4.16 and a 52-week high of $10.49.
electroCore (NASDAQ:ECOR - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.33) earnings per share for the quarter, topping analysts' consensus estimates of ($0.42) by $0.09. The company had revenue of $9.45 million during the quarter, compared to the consensus estimate of $9.49 million. electroCore had a negative net margin of 39.96% and a negative return on equity of 1,956.38%.
Insiders Place Their Bets
In other news, Director Thomas J. Errico bought 9,992 shares of the firm's stock in a transaction on Thursday, May 21st. The stock was acquired at an average price of $5.99 per share, with a total value of $59,852.08. Following the transaction, the director owned 360,071 shares of the company's stock, valued at $2,156,825.29. This trade represents a 2.85% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Joshua S. Lev sold 6,667 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $9.00, for a total transaction of $60,003.00. Following the sale, the chief financial officer owned 84,889 shares of the company's stock, valued at approximately $764,001. This trade represents a 7.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 7.80% of the stock is currently owned by insiders.
Institutional Trading of electroCore
A number of institutional investors have recently bought and sold shares of ECOR. NewEdge Advisors LLC raised its position in shares of electroCore by 857.9% in the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company's stock worth $1,083,000 after acquiring an additional 145,047 shares in the last quarter. Tejara Capital Ltd acquired a new stake in shares of electroCore in the 4th quarter valued at about $450,000. International Assets Investment Management LLC increased its position in electroCore by 15.2% in the 4th quarter. International Assets Investment Management LLC now owns 88,720 shares of the company's stock valued at $398,000 after buying an additional 11,700 shares in the last quarter. DRW Securities LLC bought a new stake in electroCore in the 4th quarter valued at about $264,000. Finally, Jane Street Group LLC increased its holdings in shares of electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company's stock valued at $246,000 after acquiring an additional 19,599 shares in the last quarter. Institutional investors own 26.74% of the company's stock.
electroCore News Roundup
Here are the key news stories impacting electroCore this week:
- Positive Sentiment: HC Wainwright raised its fiscal 2026 EPS forecast to -$1.34 from -$1.49, while Brookline Capital Markets increased its estimate to -$1.39 from -$1.43. Both firms also made slightly less pessimistic forecasts for third-quarter 2026 earnings.
- Positive Sentiment: HC Wainwright improved its estimates for the first and second quarters of 2027, forecasting losses of $0.22 and $0.30 per share, respectively, compared with prior estimates of $0.37 per share losses for both periods.
- Neutral Sentiment: Despite the upward revisions, analysts still expect substantial losses: HC Wainwright projects fiscal 2027 EPS of -$0.81, versus the current-year consensus estimate of -$1.48. The firm’s longer-range forecasts anticipate a return to profitability in 2029, followed by $0.65 EPS in 2030.
- Negative Sentiment: HC Wainwright cut its fiscal 2027 EPS forecast to -$0.81 from -$0.67 and reduced its fiscal 2028 estimate to -$0.39 from -$0.13, extending the expected period of losses.
- Negative Sentiment: Long-term estimates were sharply lowered: fiscal 2029 EPS was reduced to $0.15 from $0.36, and fiscal 2030 EPS to $0.65 from $0.90. HC Wainwright also lowered its fourth-quarter 2026 and third-quarter 2027 forecasts.
electroCore Company Profile
(
Get Free Report)
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company's lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider electroCore, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and electroCore wasn't on the list.
While electroCore currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.